| Amy Eman Abdallah, MD | |
|
700 Melvin Ave Ste 7a, Annapolis, MD 21401 | |
| (410) 280-2260 | |
| Not Available |
| Full Name | Amy Eman Abdallah |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 15 Years |
| Location | 700 Melvin Ave Ste 7a, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215161294 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | D75674 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Company Llc | 4587559026 | 192 |
| Anesthesia Company Llc | 4587559026 | 192 |
News Archive
Breast cancer cells in the laboratory that don't respond to tamoxifen may be producing high amounts of cholesterol in order to provide a kind of shield against the drug, say researchers at Georgetown University Medical Center (GUMC).
Medical workers at a hospital in Santo Domingo, Dominican Republic, went on strike Thursday after a nurse was suspected of contracting cholera, the Associated Press/Kansas City Star reports.
Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM). Designation is granted for treatment of patients sixteen years of age and younger with immune-mediated T1DM and preserved pancreatic beta-cell function, commonly referred to as juvenile diabetes.
New research shows that schizophrenia isn't a single disease but a group of eight genetically distinct disorders, each with its own set of symptoms. The finding could be a first step toward improved diagnosis and treatment for the debilitating psychiatric illness.
› Verified 3 days ago
| Entity Name | Anesthesia Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871548156 PECOS PAC ID: 4587559026 Enrollment ID: O20040216000401 |
News Archive
Breast cancer cells in the laboratory that don't respond to tamoxifen may be producing high amounts of cholesterol in order to provide a kind of shield against the drug, say researchers at Georgetown University Medical Center (GUMC).
Medical workers at a hospital in Santo Domingo, Dominican Republic, went on strike Thursday after a nurse was suspected of contracting cholera, the Associated Press/Kansas City Star reports.
Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM). Designation is granted for treatment of patients sixteen years of age and younger with immune-mediated T1DM and preserved pancreatic beta-cell function, commonly referred to as juvenile diabetes.
New research shows that schizophrenia isn't a single disease but a group of eight genetically distinct disorders, each with its own set of symptoms. The finding could be a first step toward improved diagnosis and treatment for the debilitating psychiatric illness.
› Verified 3 days ago
| Entity Name | Luminis Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
Breast cancer cells in the laboratory that don't respond to tamoxifen may be producing high amounts of cholesterol in order to provide a kind of shield against the drug, say researchers at Georgetown University Medical Center (GUMC).
Medical workers at a hospital in Santo Domingo, Dominican Republic, went on strike Thursday after a nurse was suspected of contracting cholera, the Associated Press/Kansas City Star reports.
Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM). Designation is granted for treatment of patients sixteen years of age and younger with immune-mediated T1DM and preserved pancreatic beta-cell function, commonly referred to as juvenile diabetes.
New research shows that schizophrenia isn't a single disease but a group of eight genetically distinct disorders, each with its own set of symptoms. The finding could be a first step toward improved diagnosis and treatment for the debilitating psychiatric illness.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy Eman Abdallah, MD 700 Melvin Ave Ste 7a, Annapolis, MD 21401-1515 Ph: (410) 280-2260 | Amy Eman Abdallah, MD 700 Melvin Ave Ste 7a, Annapolis, MD 21401 Ph: (410) 280-2260 |
News Archive
Breast cancer cells in the laboratory that don't respond to tamoxifen may be producing high amounts of cholesterol in order to provide a kind of shield against the drug, say researchers at Georgetown University Medical Center (GUMC).
Medical workers at a hospital in Santo Domingo, Dominican Republic, went on strike Thursday after a nurse was suspected of contracting cholera, the Associated Press/Kansas City Star reports.
Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM). Designation is granted for treatment of patients sixteen years of age and younger with immune-mediated T1DM and preserved pancreatic beta-cell function, commonly referred to as juvenile diabetes.
New research shows that schizophrenia isn't a single disease but a group of eight genetically distinct disorders, each with its own set of symptoms. The finding could be a first step toward improved diagnosis and treatment for the debilitating psychiatric illness.
› Verified 3 days ago
Dr. Steven H Parker, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 700 Melvin Ave, Suite 7a, Annapolis, MD 21401 Phone: 410-280-2260 | |
Dr. Christine G Cattaneo, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 700 Melvin Ave, Suite 7a, Annapolis, MD 21401 Phone: 410-280-2260 | |
Dr. Ashita Goel, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 700 Melvin Ave, Ste 7a, Annapolis, MD 21401 Phone: 410-280-2260 | |
Dr. Eileen M Hamill, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 700 Melvin Ave, Suite 7a, Annapolis, MD 21401 Phone: 410-280-2260 | |
Leanne Summers, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Acp 2nd Floor, North Or Desk, Annapolis, MD 21401 Phone: 443-481-1000 | |
Dr. David Anthony Nieglos, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Anne Arundel Medical Center, Annapolis, MD 21401 Phone: 410-280-2260 Fax: 410-280-2290 | |
Richard S. Ro, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 410-280-2260 |